What are the most cited papers from Rosemere Cancer Foundation?
The most cited paper from Rosemere Cancer Foundation is "EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees" (Alan Horwich et al., 2019), with 183 citations. Next come "CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations" (165) and "Exploring the decision‐making preferences of people with colorectal cancer" (80).
Showing 17 of 17 papers.Every paper is listed.
Most cited papers, sortable by citations and release date
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or
Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation;
retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown.
How the lists are chosen.